SCHEMBL30896236

SCHEMBL30896236

Fc1ccc(Nc2nc(NC3CCCCC3)c3cc(Cl)ccc3n2)cc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MERTK Q12866 5/20 0.56
CAMK2D Q13557 4/20 0.54
AURKA O14965 1/20 0.48
DAPK3 O43293 1/20 0.48
JAK2 O60674 1/20 0.48
PRKD3 O94806 1/20 0.48
MAP4K4 O95819 1/20 0.48
PAK4 O96013 1/20 0.48
ABL1 P00519 1/20 0.48
NTRK1 P04629 1/20 0.48
LCK P06239 1/20 0.48
FYN P06241 1/20 0.48
CSF1R P07333 1/20 0.48
RET P07949 1/20 0.48
MET P08581 1/20 0.48
PDGFRB P09619 1/20 0.48
PIM1 P11309 1/20 0.48
FGFR1 P11362 1/20 0.48
PDGFRA P16234 1/20 0.48
PRKACA P17612 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27223397 1.00 MERTK (0.56) MERTKCAMK2DAURKADAPK3JAK2
SCHEMBL27223370 0.90 MERTK (0.64) MERTKCAMK2DJAK2PAK4SOS1
SCHEMBL27223450 0.89 PAK4 (0.56) MERTKCAMK2DPAK4SOS1
SCHEMBL30896197 0.89 PAK4 (0.56) MERTKCAMK2DPAK4SOS1
SCHEMBL27224039 0.89 MERTK (0.56) MERTKCAMK2DADORA3ADORA2ASOS1
SCHEMBL30896205 0.89 MERTK (0.56) MERTKCAMK2DADORA3ADORA2ASOS1
SCHEMBL27223952 0.88 MERTK (0.55) MERTKCAMK2DADORA3ADORA2ASOS1
SCHEMBL30896255 0.88 CAMK2D (0.49) MERTKCAMK2DPAK4NTRK1SOS1
SCHEMBL27224032 0.88 CAMK2D (0.49) MERTKCAMK2DPAK4NTRK1SOS1
SCHEMBL27223955 0.87 MERTK (0.54) MERTKCAMK2DNPY5RCCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166626-A1 Compounds and Methods for Preventing, Treating, or Ameliorating Airway Disease UNIV JEFFERSON (US) 2024-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166626-A1 Compounds and Methods for Preventing, Treating, or Ameliorating Airway Disease ADRB2, ADRB1, ADRB3 MERTK 3423/4885CAMK2D 389/4885AURKA 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.